Cargando…
Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine–docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo
Mitochondrial-targeting therapy was considered to be a promising approach for the efficient treatment of cancer while positive charge induced nonspecific cytotoxicity severely limits its application. To overcome this drawback, a novel mitochondria targeted conjugate triphenylphosphine-docetaxel (TD)...
Autores principales: | Zhang, Jiulong, Yang, Chunrong, Pan, Shuang, Shi, Menghao, Li, Jie, Hu, Haiyang, Qiao, Mingxi, Chen, Dawei, Zhao, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058733/ https://www.ncbi.nlm.nih.gov/pubmed/29513049 http://dx.doi.org/10.1080/10717544.2018.1446475 |
Ejemplares similares
-
Construction of Hierarchical-Targeting pH-Sensitive Liposomes to Reverse Chemotherapeutic Resistance of Cancer Stem-like Cells
por: Ba, Shuang, et al.
Publicado: (2021) -
Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes
por: Shi, Menghao, et al.
Publicado: (2018) -
pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery
por: Shi, Menghao, et al.
Publicado: (2018) -
Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA
por: Zang, Xinlong, et al.
Publicado: (2016) -
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)